Emerald Advisers, LLC Cv Rx, Inc. Transaction History

Emerald Advisers, LLC

$2.36 Billion
Q1 2024

A detailed history of Emerald Advisers, LLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, Emerald Advisers, LLC holds 487,519 shares of CVRX stock, worth $5.08 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

487,519

Previous 404,389 20.56%

Holding current value

$5.08 Million

Previous $12.7 Million 30.17%

% of portfolio

0.38%

Previous 0.57%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$17.99 - $30.49 $1.5 Million - $2.53 Million	83,130 Added 20.56%	487,519 $8.88 Million
Q4 2023 Feb 05, 2024	SELL	$11.67 - $33.01 $1.13 Million - $3.19 Million	-96,684 Reduced 19.3%	404,389 $12.7 Million
Q3 2023 Oct 26, 2023	BUY	$13.56 - $18.47 $87,041 - $118,558	6,419 Added 1.3%	501,073 $7.6 Million
Q2 2023 Jul 25, 2023	BUY	$8.57 - $15.44 $581,046 - $1.05 Million	67,800 Added 15.88%	494,654 $7.64 Million
Q1 2023 May 04, 2023	BUY	$7.08 - $19.4 $1.78 Million - $4.88 Million	251,433 Added 143.33%	426,854 $3.98 Million

Q4 2022 Feb 03, 2023	BUY	$10.07 - $18.35 $153,315 - $279,378	15,225 Added 9.5%	175,421 $3.22 Million
Q3 2022 Oct 25, 2022	SELL	$6.12 - $9.5 $1.15 Million - $1.78 Million	-187,300 Reduced 53.9%	160,196 $1.5 Million
Q2 2022 Jul 29, 2022	SELL	$4.7 - $7.22 $249,288 - $382,948	-53,040 Reduced 13.24%	347,496 $2.09 Million
Q1 2022 Apr 29, 2022	BUY	$5.62 - $12.37 $187,258 - $412,168	33,320 Added 9.07%	400,536 $2.4 Million
Q4 2021 Feb 02, 2022	SELL	$10.65 - $18.61 $96,861 - $169,257	-9,095 Reduced 2.42%	367,216 $4.49 Million
Q3 2021 Oct 28, 2021	BUY	$14.65 - $26.07 $2 Million - $3.56 Million	136,591 Added 56.98%	376,311 $6.22 Million
Q2 2021 Jul 29, 2021	BUY	$28.0 - $28.0 $6.71 Million - $6.71 Million	239,720 New	239,720 $6.71 Million

Others Institutions Holding CVRX

# of Institutions

Shares Held

13.8M

Call Options Held

264K

Put Options Held

89.3K

View Full List

About CVRx, Inc.

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $215M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

More about CVRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Account

Emerald Advisers, LLC Cv Rx, Inc. Transaction History